厦门必威体育_必威体育网下载 厦门必威体育_必威体育网下载

必威体育网下载

Liver disease

We started with liver drug research, and we have a well developed pipeline for liver diseases. At present, we have introduced hepatitis B (HBV), hepatitis C (HCV), non-alcoholic fatty liver disease (NASH), liver cancer (HCC) and other related drugs for liver disease. Such as Tenofovir alafenmide, Obeticholic acid,Velpatasvir, Asunaprevir, Grazoprevir, Ledipasvir, Daclatasvir,Sofosbuvir,Lenvatinib etc.

Oncology

Paying attention to public health and solving the most difficult problems are the best embodiment of our customer supreme aim. Our team have break through the problem of drug research and development, enjoy solving problems for customers, and bring health benefits to patients. We focus on the following drugs.Such as Osimertinib, Elagolix, Anamorelin, Ribociclib,Ruxolitinib,etc.

Interest hotspots

In addition to liver disease and cancer, we are also interested in heavy, scarce, and difficult drugs. At present, we have developed the following projects. Drugs such as eczema(Crisaborole), onychomycosis (Amorolfine), hypertension (Nebivolol), chronic heart failure (Sacubitril/Valsatran, LCZ-696)etc.

> Recent News

Welcome to our booth

CPhI Shanghai

2019.6.18-20

Booth No.:W4G30

CPhI Worldwide Europe

2019.10.xx-xx

Booth No.:xxxx

CPhI India

2019.11.xx-xx

Booth No.: XXXX

Contact us for more details

sales@eddqc.com

Book Now

闽公网安备 35020502000247号

UEDBETappbob综合app手机客户端下载优发娱乐pt官网客户端